Introduction
Interactions between epithelium and stroma in tissues are an essential part of development in multicellular organs, including gastrointestines (Chung, 1995) . The stromal component is not only a supporting tissue for the gastrointestinal epithelium, but is critically involved in directing outgrowth and dierentiation. Epithelial tumors, which represent nearly 90% of human neoplasia, require epithelial-stromal interactions. Scirrhous carcinoma of the stomach is a poorly dierentiated adenocarcinoma typically characterized by growing vast ®brous stroma, and in®ltrative and rapid expansion (Sugimachi, 1993) . It should be mentioned that the prognosis of scirrhous carcinoma is still poor, despite recent advances in the treatment of gastric carcinoma (Kitamura et al., 1995) . Several peptide growth factors including epidermal growth factor (EGF) may be involved in its development and/or malignant progression. We reported transforming growth factor b1 (TGFb1) as one of the speci®c molecules secreted from scirrhous gastric carcinoma (Maehara et al., 1999) . However, the molecular pathogenesis of this disease has remained to be determined.
CCN is a novel secreted cysteine-rich peptide family (Brigstock, 1999) which stands for connective tissue growth factor (CTGF), Cysteine-rich 61 (Cyr61), and nephroblastoma overexpressed (Nov) molecule, and appears to be involved in human ®brotic disorders associated with stromal tissues. CTGF mRNA is overexpressed in numerous ®brotic disorders both in skin and in internal organs, such as in scleroderma (Shi-wen et al., 2000; Holmes et al., 2001) . Similarly, high protein levels of Cyr61 are detected throughout the reparative phase of the callus, particularly in ®brous tissue and periosteum, and in proliferating chondrocytes during repair of bone fracture (Hadjiargyrou et al., 2000) . Some CCN family members belong to immediate-early genes expressed after induction by certain oncogenes and growth factors such as EGF and TGF-b1. Sequence analysis revealed the presence of four distinct modules that exhibit homology to conserved regions in a variety of extracellular proteins (Bork, 1993) . Module I is an amino-terminal domain that has homology to the insulin-like growth factor binding proteins (IGF-BP). Module II is a domain with homology to Von Willebrand factor type C (VWC) repeats and may participate in protein complex formation. Module III is a thrombospondin (THBS) type I domain and may be involved in the binding of CCNs to sulfated glycosaminoglycans either on the cell surface or in the extracellular matrix. Module IV is a cysteine knot (CK) domain, which has been identi®ed in several other signaling peptides (such as TGF-b, platelet derived growth factor and nerve growth factor), and may participate in dimerization and receptor binding. Recently, module IV was found to be involved in heparin binding (Chen et al., 2000) . While the CCN family is closely associated with the function of matrix proteins and growth factors, which members contribute to the scirrhous carcinogenesis of the stomach remained to be identi®ed. We have now identi®ed a variant of the CCN family member in excised scirrhous gastric carcinoma tissues. Ectopic expression revealed this variant to be an oncogene enhancing the invasive phenotype of gastric carcinoma cells. This protein is apparently involved in aggressive progression of the carcinoma.
Results

Identification of the human CCN gene in scirrhous gastric carcinoma
To isolate the human CCN family member gene that may be preferentially expressed in scirrhous carcinoma tissues of the stomach, targeted dierential displays for CCN consensus sequences in the four modules (Brigstock, 1999 ) were done essentially as described (Tanaka et al., 1998) . As shown in Figure 1a , degenerate primers for the IGF-BP and THBS motifs (IU; 5'-GAYGGNTGYGGNTGYTGYCGNGTNTGYGC-3' and IIIL; 5'-CCRCANGWTYTTYTTNSWRCA-3', respectively) were used for RT ± PCR ampli®cation. Sequentially, a small product was detected from the scirrhous type of gastric carcinoma, but not from the non-scirrhous carcinoma (Figure 1b) . Direct sequence analysis identi®ed this product to be a variant fragment completely lacking the sequence of the second module derived from WISP1 (Figure 1c) , one of the novel members of CCN family (Pennica et al., 1998) . Fulllength cDNA of the variant WISP1 was cloned from human scirrhous carcinoma tissue of the stomach and named WISP1v, as shown in Figure 2a ,b.
As shown in Figure 2c , immunoblot of cell lysates of the transfectantants with the epitope-tagged WISP1 cDNA and WISP1v cDNA identi®ed speci®c proteins of approximately 40 kDa and 30 kDa, respectively, which are compatible with the predicted sizes (Pennica et al., 1998) . In the supernatant, the dominant expression of the protein was detected in WISP1v transfectants, but not in WISP1 transfectants. The WISP1v lacking the module of VWC was found to be a typically secreted protein compared to the wild-type WISP1. Additional immunoblotting under nonreducing conditions revealed that protein complex Figure 1 Identi®cation of cancer-speci®c genes of the CCN family in non-scirrhous or scirrhous gastric carcinoma tissues. (a) Schematic structure of CCN family protein composed of the signal peptide (a black box), module I homologue to the insulin-like growth factor binding proteins (IGF-BP), module II homologue to the Von Willebrand factor type C repeats (VWC), module III homologue to the thrombospondin type I domain (THBS), and module IV of the cysteine knot domain (CK) (large boxes). Conserved cysteine residues are indicated by thin bars. CCN consensus sequences in the four modules (I ± IV) are represented, and the arrows indicated the corresponding PCR primers. (b) Expression pattern of CCN family by RT-PCR using IU and IIIL primers, in tissue samples of gastric carcinoma (T) compared to normal adjacent mucosa (N) derived from non-scirrhous (Ns) or scirrhous types (Sc). The number indicates the clinical sample. A small product ampli®ed from the scirrhous type of gastric carcinoma, but not from the non-scirrhous carcinoma. (c) Direct sequence analysis on the small PCR product from the scirrhous gastric carcinoma, revealed a sole fragment lacking the second module VWC of WISP1 (Pennica et al., 1998) formation at approximately 60 kDa and 110 kDa both in the WISP1 and WISP1v samples (Figure 2d ). It is noteworthy that the potential WISP1v monomer (30 kDa), but not the WISP1 monomer (40 kDa), was observed. On the other hand, an approximately 80 kDa complex with the WISP1 protein was recognized.
Expression of WISP1v in human carcinoma tissue of the stomach
An RT ± PCR speci®c for the WISP1v mRNA was then used to search for expression of this product in gastric carcinoma tissue. The lower PCR primer was selected to span the deleted module II for speci®c detection of the WISP1v mRNA. As demonstrated in Figure 2e , the WISP1v mRNA was seen to be expressed predominantly in scirrhous carcinoma tissues. No expression of WISP1v mRNA was recognized in any adjacent normal mucosa of the stomach. Further investigation of 110 clinical tissue specimens revealed the expression of WISP1v mRNA in 18 of 21 (86%) scirrhous tumors, but in only 13 of 89 (15%) non-scirrhous tumors of the stomach (P50.0001; Fisher's exact test). Additional RT ± PCR for expression analysis using Clontech cDNA libraries exhibited no expression of WISP1v in any normal tissue except for the placenta sample which weakly expressed the variant. Microdissection analysis revealed the potent expression of WISP1v in ®broblast-rich stroma, but not in cancer cell nests within the scirrhous gastric carcinoma tissues (Figure 2e ). Expression of WISP1v was never evident in all the gastric carcinoma cell lines examined. Thus, there is a potential correlation between WISP1v expression and development of the stroma within scirrhous gastric carcinoma. WISP1 has two closely related homologues, WISP2 and WISP3, which were identi®ed based on their increased expression in Wnt1 transformed cells. WISP2 mRNA were detected in stomach tissues, but lower expression was identi®ed in carcinoma tissue compared to normal mucosa of the stomach, as noted in cases of colon cancer by Pennica et al., 1998 . WISP3 mRNA was not detected in our examined tissues, and neither WISP2 variant nor WISP3 variant was observed.
A BLAST search of the human genome (NCBI) revealed that the WISP1 gene is located on the chromosome 8q24.1 ± q24.3. As shown in the Figure 3 , we analysed the sequence of WISP1 genome and con®rmed that the WISP1 coding region consists of ®ve exons. It is noteworthy that the third exon encodes the entire VWC domain that was deleted in WISP1v cDNA. WISP1v was found to be a product the result of alternative splicing of the entire exon. According to the sequence analysis of the WISP1 intron:exon junction of the gastric cancer tissues, no mutation was detected in all the examined samples expressing the WISP1v.
Oncogenic potentials of WISP1v
Previous studies showed other CCN members were closely related to cell transforming potentials. We analysed the transforming activity of WISP1 clones, using NIH3T3 ®broblasts, as described previously (Tanaka et al., 1996) . As shown in Figure 4a , WISP1v (lacking the second module of VWC) had remarkable eects on cellular transformation. The transfection eciency determined using¯uorescent co-transfection analysis was approximately 10 ± 12% eciency in each transfection assay. While wild-type WISP1 also displayed transforming potentials in NIH3T3 ®broblasts, the eciency was a mean threefold lower in transformation foci, compared to WISP1v. As a negative control, transforming foci were not observed in transfection of WISP2 (Zhang et al., 1998) . Next, the growth of stable transfectants of WISPs was examined. To avoid clonal deviation of transfection, the pooled transfectants with a bicistronic vector pIRESneo including each cDNA were used following drug selection (Clontech). The neomycin resistant clones were equally observed following the drug selection, potentially indicating the expression of each cDNA, at similar levels. As shown in Figure 4b , transfectants of WISP1 and WISP1v grew rapidly compared to ®ndings with mock and WISP2 transfectants. After con¯uent growth on the culture plastics, the transfectants of WISP1s piled up into multilayed structures and formed aggregates, as shown in Figure 4c . In contrast, the mock-transfectants showed no multilayed and aggregated growth, nor did the WISP2-transfected NIH3T3 cells. It should be mentioned that a more rapid and remarkable aggregate formation was recognized in the WISP1v transfectants (Figure 4b,c) .
Effects of WISP1v on gastric carcinoma cell migration
Other CCN members such as CTGF and Cyr61 were found to stimulate cell migration (Kireeva et al., 1996; Babic et al., 1999) . In addition, Babic et al., 1998 reported that Cyr61 promotes tumorigenesis of gastric carcinomas. Finally, eects of WISP1v on invasive phenotypes of human gastric carcinoma cells were investigated using Boyden Chamber methods, essentially as described (Tsujii et al., 1998) . Stably transfected NIH3T3 cells with mock, WISP1, WISP1v or WISP2 were seeded on the bottom of the lower chamber and served as chemoattractant cells ( Figure   4d ). The upper chamber with a ®lter was inserted so as to contain a monolayer of KATO-III gastric carcinoma cells plated onto the type I collagen layer. Figure 4e shows the numbers of gastric carcinoma cells that migrated through the collagen layer onto ®lters in the bottom of the upper chamber. Migrated gastric carcinoma cells were approximately ®vefold increased by co-cultures of the WISP1v-transfectants, compared to the mock-transfectants. Such a signi®cant upregulation of cell invasion was not induced by co-cultures of transfectants with WISP1 or WISP2 (Figure 4e) . Therefore, WISP1v is a striking enhancer for gastric carcinoma cell invasion into the stromal matrix.
Discussion
Tumor-stromal interaction is one essential part of malignant progression in vivo (Chung, 1995) . During tumor development, stromal ®broblasts participate in providing the extracellular matrix as an anchorage for the tumor cells. Stroma derived growth as well as interactions between neoplastic cells and the extracellular matrix can play a role in both tumor cell migration and proliferation. The extracellular matrix may also function as a reservoir for growth factors. Various growth factors mediate such functions in an autocrine and/or paracrine fashion.
In this study, we identi®ed a variant of CCN growth factor from scirrhous gastric carcinoma rapidly grow- ing with extensive ®brous stroma. The typical CCN growth factor protein is composed of the four modules; IGF-BP, VWC, THBS, and CK (Bork, 1993) . The variant derived from scirrhous carcinoma lacks the second module of VWC of WISP1, and is designated as WISP1v. WISP1 was originally found to be as a speci®c molecule induced by the Wnt1 oncogene. The Wnt family of signaling proteins regulate cell fate, motility, morphology and proliferation, thereby indicating critical roles in carcinogenesis (Peifer and Polakis, 2000) . In mammalian cells, Wnt family members initiate signals by binding to the seventransmembrane receptors, Frizzled, one of which we found to be an overexpressed molecule in carcinoma tissues (Tanaka et al., 1998) . The Wnt-Frizzled signaling stabilizes b-catenin protein that interacts with transcription factor TCF/Lef1, forming a complex that appears in the nucleus and binds TCF/Lef1 target DNA elements to activate transcription such as WISPs (Xu et al., 2000) . Together with additional functions of b-catenin that directly regulate cell attachment as a Cadherin's anchor protein, the Wnt-b-catenin pathway to gene expression apparently contributes to the invasive potential of cancer (Peifer and Polakis, 2000) .
It has been suggested that the dierent modules of CCNs can function independently in dierent cell types (Bork, 1993; Brigstock, 1999) . The oncogenic form of Nov, isolated from myeloblastomatosis-associated virus-induced nephroblastoma, had a truncated structure lacking the ®rst module of IGF-BP, and capable of inducing cell transformation in ®broblasts. In contrast, wild-type Nov that is negatively regulated by growth factors (Scholz et al., 1996) , has suppressor activity for cell growth (Joliot et al., 1992) . Xu et al. reported that WISP1 induced morphological transformation, accelerated cell growth, and enhanced saturation density in normal rat kidney ®broblasts (Xu et al., 2000) , while the suppression of melanoma growth by a mouse orthologue of WISP1 was reported by Hashimoto et al., 1998. WISP2 lacks the fourth module of CK (Pennica et al., 1998) . A rat orthologue of WISP2 was found to be a negative regulator of cell transformation (Zhang et al., 1998) . Kumar et al. (1999) reported that WISP2 is a secreted protein which positively regulates osteoblast functions. Unlike all other known CCN proteins, four of 10 conserved cysteine residues are not recognized in the VWC module of WISP3 that is frequently mutated in patients with progressive pseudorheumatoid dysplasia (Hurvitz et al., 1999) . In our experiments, WISP1v lacking the second module of VWC induced a striking cellular transformation and a rapid piling-up forms of growth. Furthermore, WISP1v transfectants enhanced the invasive phenotype of co-cultured gastric carcinoma cells, while wild-type WISP1 had no such potential. The dierence in biological eects between the WISP1 and WISP1v expressing cells may re¯ect the ability of the cells to better process the variant form, as shown in Figure 2c , d.
According to the human genomic analysis, the WISP1 coding region was found to consist of ®ve exons (Figure 3) . Interestingly, each module of WISP1 was encoded by each exon, as noted for other CCN members (Brigstock, 1999) . Alternative splicing of the entire third exon revealed production of WISP1v mRNA. No genomic mutation in the intron:exon junction was detected in all of the examined samples expressing the WISP1v, hence another mechanism for alternative splicing of the third exon is involved. WISP1v is expressed in the ®broblast-rich stroma adjacent to the gastric cancer, and weakly in normal placenta tissue. These results imply that the variant does not result from genetic nor epigenetic changes in a cancer cell, but rather from eects of the cancer cell upon the adjacent stroma. The tumor cells make factors that induce stromal cells to produce WISP1v, which in turn aects tumor cell growth or invasiveness.
Gastric carcinoma is the second most common malignancy worldwide, and tumor progression critically determines the clinical signi®cance (Sugimachi, 1993) . The scirrhous type of gastric cancer with a vast stroma has the poorest prognosis as invasion is rapid. Targeting antitumor therapy to stromal elements required for tumor growth may prove to be a pertinent strategy for retarding the growth of solid neoplasms, since normal tissue is unlikely to show genetic plasticity that often accompanies malignant transformation, an event that allows transformed cells to rapidly acquire resistance to chemotherapeutic agents. A better understanding of stromal contributions will likely increase awareness of the importance of molecules such as WISP1v in the growth of solid malignancies and identi®cation of therapeutic targets focusing on the tumor stroma is expected to be rewarding.
Materials and methods
Cloning of the human CCN genes
To isolate CCN family member genes expressed in human gastric carcinoma tissues, the consensus sequences in the four modules (Brigstock, 1999) , DGCGCCRVCA (IGF-BP), CTCIDGAVAC (VWC), CSKTCGMGIS (THBS) and CGVCTDGRCC (CK) as shown in Figure 1a , were utilized, essentially as described elsewhere (Tanaka et al., 1998) . Degenerate primers for the consensus sequences were synthesized for PCR ampli®cation following reverse transcription of RNA extracted from human gastric tumors excised at surgery in our department. Each ampli®ed fragment was individually isolated and analysed by direct sequencing. Following identi®cation of a carcinoma-speci®c CCN gene, additional PCR ampli®cations were done to isolate a full cDNA.
Expression analysis in clinical samples
Expression of the carcinoma-related CCN gene was examined by speci®c PCR ampli®cation following RT reaction on RNA extracted from surgical specimens (Tanaka et al., 1998) . Gastric carcinoma tissues derived from 110 individuals with histopathologically diagnosed adenocarcinoma and surrounding normal gastric mucosa were used. Among them, 21 adenocarcinomas were diagnosed as the scirrhous type with stromal ®brosis. Twenty-®ve cycle PCR was run using primers 5'-TCGGTCGATGCCTGTGCCACTG-3' and 5'-TCCACCTCACCAACAGCATGTGC-3', to amplify 400-bp fragments. As a control for mRNA quality, RT ± PCR of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was done using primers 5'-GTCAACGGATTTGGTCTGTATT-3' and 5'-AGTCTTCTGGGTGGCAGTGAT-3', to amplify 560-bp fragments. All PCR primers were selected to span the introns to detect speci®c mRNA sequences. In addition, the expression in the normal tissues was analysed, using autopsy specimens and cDNA libraries (Clontech, Palo Alto, CA, USA).
Construction of the expression plasmids
The full coding region of the CCN gene was subcloned into a mammalian expression vector pcDNA3 (Invitrogen, Carlsband, CA) or a bicistonic expression vector pIRESneo (Clontech). A FLAG epitope sequence (DYKDDDDK) was tagged at the COOH terminus of the CCN gene, and ligated to a mammalian expression vector pcDNA3 (Invitrogen Co., Carlsband, CA, USA). In addition, the full coding regions were subcloned into a bicistonic expression vector pIRESneo (Clontech, Palo Alto, CA, USA), that contains the internal ribosome entry site (IRES) of the encephalomyocarditis virus. The expression cassette contains a single promoter which, in combination with the IRES, permits the translation of both the gene of interest and the neomycin-resistant gene from the same mRNA.
Cell transfection assays
NIH3T3 cells were cultured in Dulbecco's modi®ed Eagle's medium (GIBCO BRL, Life Technologies, Inc., Gaithersburg, MD, USA) supplemented with 10% heat inactivated fetal bovine serum (Sigma Chemical Company, St. Louis, MO, USA). 1610 5 cells in 3.5 cm dish were transfected with 2 mg of pcDNA3 vector (mock) or pcDNA3 containg FLAGtagged CCN gene by use of Lipofectamine (GIBCO BRL) according to the manufacturer's instructions. Two days later, the cell lysate and the supernatant medium were analysed to detect protein production by Western blots using anti-FLAG M2 antibody (Sigma, St. Louis, MI, USA).
For analysis of transforming potentials, focus formation assays were carried out as described (Tanaka et al., 1996) . NIH3T3 cells were transfected with pIRESneo vector (mock) or pIRESneo containing the CCN gene, followed by a split into 1 : 20 at 2 days. Transfected cells were cultured for 13 ± 15 days until foci appeared. Transfection eciencies were identi®ed by co-transfection with pTracer plasmid carryinḡ uorescent protein sequence (Invitrogen). Cells were washed twice with phosphate-buered saline and twice with 70% ethanol; stained with xylene cyanol FF buer (saturated in 70% ethanol) for 5 min, and then washed three times with 70% ethanol. Dishes were dried in air for 15 min before counting the foci. The transfected NIH3T3 cells were grown with selection in the presence of 600 mg/ml of G418 (GIBCO BRL), and pooled clones were used as stable tramsfectants to avoid clonal deviation of transfection. To examine growth of the transfectants, 5610 4 cells were seeded on a 3.5 cm plastic dish. Growth of the transfectants was assessed by counting the number of cells dissociated by trypsinization and viable cells were counted after Trypan blue staining.
Cell migration assays
Eects of the CCN on invasive phenotypes of human gastric carcinoma cells were determined in a co-culture method, essentially as described (Tsujii et al., 1998) . To assay for migration of KATO-III gastric carcinoma cells derived from a scirrhous tumor, polycarbonate ®lters (8 mm pore size) coated with type I collagen were used. Stably transfected NIH3T3 cells were seeded in the outer chamber, and at con¯uence without piling up, the inner chamber was transferred to the outer chamber, and gastric carcinoma cells were suspended in serum-free medium and seeded in the inner chamber. Cell movement was evaluated toward a gradient of conditioned medium of mock or the CCN gene transfectants. The cells were incubated at 378C for 4 h. Following the incubation period, nonmigrating cells on the upper surface of the ®lter were removed, and the cells that had migrated onto the ®lter were counted, using a microscope.
